Biotech Values

[mcbio]

DYAX
This report has HAE-market related information that may be of interest:
bir-llc.com/wp-content/uploads/2012/04/BER-VPHM-Cinryze-Report-11-9-2011.pdf

Thanks very much. That doesn't paint a great picture for Firazyr's competition, including Kalbitor and possibly DX-2930 as well. I've moved on from DYAX for time being in light of capital structure and this article kind of cements that for me, for better or worse.